The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.
The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.
Rebecca Brown, vice chancellor for strategic initiatives and university governance at Washington University in St. Louis, has been named to the St. Louis Business Journal’s “Most Influential Business Women” class of 2025.
Frank A. Podosek, a professor emeritus of earth, environmental and planetary sciences at Washington University in St. Louis, died June 8 in Florida. He was 83 years old.
An interdisciplinary research team at Washington University in St. Louis has found that variability in sleep patterns in people experiencing pregnancy can effectively predict preterm birth.
Fixing problems with cholesterol metabolism might help slow or prevent age-related macular degeneration, a leading cause of blindness in older adults, a new WashU Medicine study in mice has shown.
Occupational therapy faculty member Kelly Harris, at WashU Medicine, will receive a $425,000 award to develop and test a technology-enabled care coordination service model to support Black youth with asthma.
Biologist Keith Hengen in Arts & Sciences at Washington University in St. Louis says “criticality” is the key to understanding how the brain works — and how to keep it free from Alzheimer’s and other diseases.
The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.